Oklahoma House · 2026 Regular Session

HB 3834: Ibogaine clinical trials; Oklahoma Breakthrough Therapy Act; terms; requirements for drug developers; contractual terms; intellectual property rights…

Fourth Reading · May 6, 2026 · Yeas 69, nays 21

How each party voted

Democrats
Yea 16 · Nay 0 · Not voting 2
Republicans
Yea 53 · Nay 21 · Not voting 7

Speaker Kyle Hilbert voted yea.

Bill

Bill
HB 3834
Motion
Fourth Reading
Date
May 6, 2026, 15:12
Session
2026 Regular Session
Yeas–nays
Yeas 69, nays 21; 9 didn't vote (9 excused, 0 for a conflict of interest)
Result
Passed, as the official record marks it

Official record: the Journal (PDF) ↗
The measure's page on the Legislature's site ↗

The chamber on this vote

Seats are today's members, liberal to conservative; members who have left aren't shown.

← Most liberalThe aisleMost conservative →

How each member voted

Yea (69)

Nay (21)

Excused (9)